Blog

Recruitment of clinical trial participants continues to be a major challenge, in spite of widespread investment and innovations. Recruitment delays and shortfalls increase study timelines and increase costs in an environment where everyone is trying to do more with fewer resources.

In the third installment of the ACRP at 50 Fellows blog series, Suzanne Kincaid, CCRA, ACRP-PM, FACRP, shares how ACRP has helped her grow into an industry leader at the forefront of emerging trends in clinical research.

Protocol deviations are a familiar part of clinical research, yet historically there has been little regulatory clarity around their classification and management. Clinical teams are now expected to demonstrate stronger inspection readiness, consistent deviation classification, and well-reasoned documentation. By applying the new structure and definitions, clinical research professionals will be able to strengthen deviation categorization and reduce operational risk across diverse study environments.

Women's History Month is a wonderful opportunity to celebrate women leaders. Hear from a group of high-achieving women—who will lead a Signature Series panel discussion at ACRP 2026— describe the leadership skills and learnings that helped advance their careers.

Delays to study start-up can undermine clinical research timelines and efficiency. All stakeholders should engage in overcoming these delays. In a new white paper, the Site-Sponsor Consortium advocates for harmonization of Confidentiality Disclosure Agreements (CDAs). These pre-negotiated agreements between a sponsor/contract research organization and a site/institution are an efficient solution, covering confidentiality for future feasibility activities and studies.